Alps Advisors Inc Biotechnology

Alps Advisors Inc

$14.8 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
SVRA Savara Inc	$389M	$544,000 0.0% of portfolio	128,501	Q3 2024 Added 19.23%
PLRX Pliant Therapeutics, Inc.	$655M	$540,000 0.0% of portfolio	48,238	Q3 2024 Added 2.47%
ARCT Arcturus Therapeutics Holdings Inc.	$467M	$506,000 0.0% of portfolio	21,838	Q3 2024 Reduced 27.48%
ALLO Allogene Therapeutics, Inc.	$328M	$490,000 0.0% of portfolio	175,285	Q3 2024 Added 7.63%
YMAB Y M Abs Therapeutics, Inc.	$462M	$449,000 0.0% of portfolio	34,231	Q3 2024 Added 0.02%
CELC Celcuity Inc.	$208M	$448,000 0.0% of portfolio	30,093	Q3 2024 Added 9.91%
ANNX Annexon, Inc.	$243M	$440,000 0.0% of portfolio	74,344	Q3 2024 Added 4.6%
FULC Fulcrum Therapeutics, Inc.	$179M	$439,000 0.0% of portfolio	123,009	Q3 2024 Added 153.74%
URGN Uro Gen Pharma Ltd.	$284M	$433,000 0.0% of portfolio	34,149	Q3 2024 New
FDMT 4 D Molecular Therapeutics, Inc.	$247M	$425,000 0.0% of portfolio	39,343	Q3 2024 Reduced 2.51%
ADMA Adma Biologics, Inc.	$4.22B	$392,000 0.0% of portfolio	19,650	Q3 2024 New
VRTX Vertex Pharmaceuticals Inc	$120B	$374,000 0.0% of portfolio	805	Q3 2024 Reduced 62.24%
HRMY Harmony Biosciences Holdings, Inc.	$2.06B	$369,000 0.0% of portfolio	9,244	Q3 2024 Reduced 17.67%
UTHR United Therapeutics Corp	$17.2B	$364,000 0.0% of portfolio	1,016	Q3 2024 Reduced 26.38%
AVXL Anavex Life Sciences Corp.	$712M	$363,000 0.0% of portfolio	63,979	Q3 2024 Reduced 3.13%
ALEC Alector, Inc.	$327M	$360,000 0.0% of portfolio	77,232	Q3 2024 Added 2.73%
BMRN Biomarin Pharmaceutical Inc	$12.1B	$358,000 0.0% of portfolio	5,100	Q3 2024 New
CPRX Catalyst Pharmaceuticals, Inc.	$2.18B	$348,000 0.0% of portfolio	17,509	Q3 2024 Reduced 18.45%
ALT Altimmune, Inc.	$420M	$337,000 0.0% of portfolio	54,993	Q3 2024 Reduced 0.56%
EXEL Exelixis, Inc.	$11.7B	$337,000 0.0% of portfolio	13,000	Q3 2024 New
TGTX Tg Therapeutics, Inc.	$5.03B	$335,000 0.0% of portfolio	14,350	Q3 2024 New
HALO Halozyme Therapeutics, Inc.	$6.66B	$325,000 0.0% of portfolio	5,687	Q3 2024 Reduced 32.2%
REGN Regeneron Pharmaceuticals, Inc.	$80.7B	$325,000 0.0% of portfolio	310	Q3 2024 New
AURA Aura Biosciences, Inc.	$260M	$313,000 0.0% of portfolio	35,211	Q3 2024 Reduced 8.9%
TBPH Theravance Biopharma, Inc.	$632M	$301,000 0.0% of portfolio	37,436	Q3 2024 Reduced 1.34%
ACIU Ac Immune Sa	$284M	$289,000 0.0% of portfolio	76,630	Q3 2024 Reduced 0.96%
ITOS I Teos Therapeutics, Inc.	$293M	$270,000 0.0% of portfolio	26,475	Q3 2024 Reduced 6.1%
GHRS Gh Research PLC	$474M	$256,000 0.0% of portfolio	38,362	Q3 2024 Reduced 5.45%
ALDX Aldeyra Therapeutics, Inc.	$290M	$245,000 0.0% of portfolio	45,536	Q3 2024 Reduced 1.71%
INZY Inozyme Pharma, Inc.	$106M	$233,000 0.0% of portfolio	44,562	Q3 2024 Reduced 7.67%
STRO Sutro Biopharma, Inc.	$136M	$225,000 0.0% of portfolio	65,061	Q3 2024 Added 2.0%
AVIR Atea Pharmaceuticals, Inc.	$283M	$216,000 0.0% of portfolio	64,692	Q3 2024 Reduced 1.5%
VNDA Vanda Pharmaceuticals Inc.	$286M	$206,000 0.0% of portfolio	44,036	Q3 2024 Reduced 3.0%
ZNTL Zentalis Pharmaceuticals, Inc.	$199M	$206,000 0.0% of portfolio	56,216	Q3 2024 Added 1.45%
PROK Prokidney Corp Ord Shs Cl A(Cy	$104M	$187,000 0.0% of portfolio	97,396	Q3 2024 Added 95.39%
ENTA Enanta Pharmaceuticals Inc	$187M	$166,000 0.0% of portfolio	16,038	Q3 2024 Reduced 2.93%
HLVX Hille Vax, Inc.	$63.5M	$66,000 0.0% of portfolio	37,705	Q3 2024 Reduced 2.79%
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	70,578	Q3 2024 Reduced 6.65%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.